Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 914-922

  Ye, Chun Sheng ^a   Zhou, Dong Ni ^a   Yang, Qing Qing ^b   Deng, Yan Fei ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; Invasion; Nasopharyngeal carcinoma; Proliferation; SATB1

Indexed keywords

MATRIX ATTACHMENT REGION BINDING PROTEIN; SATB1 PROTEIN, HUMAN;

BIOSYNTHESIS; CELL MOTION; DRUG RESISTANCE; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; DRUG RESISTANCE, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84899514091     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, Huang TL and Huang HY. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 2008; 72: 356-364.
2. Dickinson LA, Joh T, Kohwi Y and Kohwi-Shigematsu T. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 1992; 70: 631-645.
3. Dickinson LA, Dickinson CD and Kohwi-Shigematsu T. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region. J Biol Chem 1997; 272: 11463-11470.
4. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY and Kohwi-Shigematsu T. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 2000; 14: 521-535.
5. Galande S, Dickinson LA, Mian IS, Sikorska M and Kohwi-Shigematsu T. SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol 2001; 21: 5591-5604.
6. Han HJ, Russo J, Kohwi Y and Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187-193.
7. Peng ZK, Yang DH, Li XH, Huang Y, Zhang GQ, Zhong KB, Bi MP and Li GH. [Expression of special AT-rich sequence-binding protein 1 mRNA in hepatocellular carcinoma and its clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao 2011; 31: 1207-1211.
8. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K and Tong Q. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 2010; 24: 981-987.
9. Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Ericson-Lindquist K, Uhlen M, Jirstrom K and Eberhard J. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol 2012; 7: 115.
10. Shen Z, Zeng Y, Guo J, Wu Y, Jiang X, Ding R, Wu C, Li R, Luo B and Zeng C. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression. J Transl Med 2013; 11: 217.
11. Endo K, Shackelford J, Aga M, Yoshizaki T and Pagano JS. Up-regulation of SATB1 by EBV LMP1 in human nasopharyngeal cells and nasopharyngeal cancer. J Gen Virol 2013 Mar; 94: 507-13.
12. Stetler-Stevenson WG, Aznavoorian S and Liotta LA. Tumor cell interactions with the extracel lular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
13. Helfman D, Kim E, Lukanidin E and Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005; 92: 1955-1958.
14. Zhang M, Zhu GY, Gao HY, Zhao SP and Xue Y. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma. J Surg Oncol 2011; 103: 243-247.
15. Salven P, Lymboussaki A, Heikkilä P, Jääskela-Saari H, Enholm B, Aase K, Von Euler G, Eriksson U, Alitalo K and Joensuu H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998; 153: 103.
16. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ and Jiang PC. Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med 2012; 10: 149.
17. Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P and Tian D. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 2012; 32: 1064-1078.
18. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu XP and Xu ZD. Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 2010; 101: 80-86.
19. Vermeulen K, Berneman ZN and Van Bockstaele DR. Cell cycle and apoptosis. Cell proliferation 2003; 36: 165-175.